Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV). 1 Nearly 9 out of 10 women who die from cervical cancer live in low- and middle-income countries.2 For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease. Roche’s HPV self-sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at…
Read More#BREAKING: Cervical Cancer Self Testing Solution Launched
